Document Detail


Lipoprotein oxidation in dyslipidemia: insights into general mechanisms affecting lipoprotein oxidative behavior.
MedLine Citation:
PMID:  7670748     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atherosclerosis susceptibility associated with elevations in specific populations of apolipoprotein-B-containing particles may involve increased oxidation of lipoproteins and associated changes in their biological properties. Lipoprotein oxidation may be potentiated by the greater mass of oxidizable lipoprotein substrates, as well as by a greater intrinsic susceptibility of the specific forms of lipoproteins that arise in these disorders. The atherogenic consequences of increased lipoprotein oxidation may be further enhanced by a greater relative potency or toxicity of the oxidized products of these lipoprotein subpopulations. This review addresses these facets of lipoprotein oxidation in several forms of dyslipidemia, and in view of both differences between and commonalities among these disorders, proposes that lipoprotein oxidative behavior is determined by a complex array of physical, chemical, and metabolic factors.
Authors:
D L Tribble
Related Documents :
7609598 - Uptake by macrophages of low-density lipoprotein damaged by nitrogen dioxide in air.
11577738 - Effect of germanium-132 on low-density lipoprotein oxidation and atherosclerosis in kur...
16242018 - Hdl enhances oxidation of ldl in vitro in both men and women.
19818318 - Efficient enzymatic preparation of hydroxycinnamates in ionic liquids enhances their an...
19006168 - 9,10-diarylanthracenes as molecular switches: syntheses, properties, isomerisations and...
14987048 - Application of ring-closing metathesis reactions in the synthesis of epothilones.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review    
Journal Detail:
Title:  Current opinion in lipidology     Volume:  6     ISSN:  0957-9672     ISO Abbreviation:  Curr. Opin. Lipidol.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-10-19     Completed Date:  1995-10-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9010000     Medline TA:  Curr Opin Lipidol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  196-208     Citation Subset:  IM    
Affiliation:
Department of Molecular and Nuclear Medicine, Lawrence Berkeley Laboratory, University of California, Berkeley, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoproteins B / blood,  chemistry
Fatty Acids, Unsaturated / blood
Humans
Hydrogen Peroxide
Hyperlipidemias / blood*
Lipid Peroxidation*
Lipoproteins / blood*
Oxidation-Reduction
Chemical
Reg. No./Substance:
0/Apolipoproteins B; 0/Fatty Acids, Unsaturated; 0/Lipoproteins; 7722-84-1/Hydrogen Peroxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental...
Next Document:  Triglyceride-rich lipoproteins and the progression of coronary artery disease.